EX-10.62 4 dex1062.htm DIALYSIS ORGANIZATION AGREEMENT BETWEEN DAVITA INC. AND AMGEN USA INC. Confidential Treatment Dialysis Organization Agreement Information SheetDialysis Organization Agreement • May 5th, 2020 • California
This Information Sheet sets forth certain definitions and other information as used in the attached Dialysis Organization Agreement. As used in such Dialysis Organization Agreement, the following terms shall have the meanings ascribed below:
Dialysis Organization Agreement Information SheetDialysis Organization Agreement • December 29th, 2011 • Davita Inc • Services-misc health & allied services, nec • California
This Information Sheet sets forth certain definitions and other information as used in the attached Dialysis Organization Agreement. As used in such Dialysis Organization Agreement, the following terms shall have the meanings ascribed below:
EXHIBIT 10.19 Dialysis Organization Agreement Information Sheet This Information Sheet sets forth certain definitions and other information as used in the attached Dialysis Organization Agreement. As used in such Dialysis Organization Agreement, the...Dialysis Organization Agreement • March 15th, 2006 • Renal Care Group Inc • Services-misc health & allied services, nec • California
DELETED] = Portions of this exhibit are subject to a request for confidential treatment and have been redacted and filed separately with the Securities and Exchange Commission.Dialysis Organization Agreement • December 29th, 2011 • Davita Inc • Services-misc health & allied services, nec
This Amendment No. 2 (“Amendment No. 2”) to Dialysis Organization Agreement No. 920110141 is entered into effective as of July 1, 2011 (“Amendment No. 2 Effective Date”) by and between Amgen USA Inc. (“Amgen”), a wholly-owned subsidiary of Amgen Inc., and DaVita Inc. (“Dialysis Center”) (Amgen and Dialysis Center each a “Party” and together, the “Parties”).
DELETED] = Portions of this exhibit are subject to a request for confidential treatment and have been redacted and filed separately with the Securities and Exchange Commission.Dialysis Organization Agreement • August 4th, 2011 • Davita Inc • Services-misc health & allied services, nec
This Amendment No. 2 (“Amendment No. 2”) to Dialysis Organization Agreement No. 920110141 is entered into effective as of July 1, 2011 (“Amendment No. 2 Effective Date”) by and between Amgen USA Inc. (“Amgen”), a wholly-owned subsidiary of Amgen Inc., and DaVita Inc. (“Dialysis Center”) (Amgen and Dialysis Center each a “Party” and together, the “Parties”).
Dialysis Organization Agreement Information SheetDialysis Organization Agreement • May 8th, 2006 • Davita Inc • Services-misc health & allied services, nec • California
This Information Sheet sets forth certain definitions and other information as used in the attached Dialysis Organization Agreement. As used in such Dialysis Organization Agreement, the following terms shall have the meanings ascribed below:
Dialysis Organization Agreement Information SheetDialysis Organization Agreement • February 25th, 2011 • Davita Inc • Services-misc health & allied services, nec • California
This Information Sheet sets forth certain definitions and other information as used in the attached Dialysis Organization Agreement. As used in such Dialysis Organization Agreement, the following terms shall have the meanings ascribed below:
Dialysis Organization AgreementDialysis Organization Agreement • March 2nd, 2006 • Fresenius Medical Care AG & Co. KGaA • Services-misc health & allied services, nec • Delaware
This Dialysis Organization Agreement (this “Agreement”) is made by and between Amgen USA Inc. (“Amgen”) and National Medical Care, Inc. (“NMC”) to set forth the terms and conditions upon which NMC shall purchase Products and Amgen shall pay rebates.
